Endoscopic Over Under Cartilage Tympanoplasty Is Not Inferior to Underlay Cartilage Tympanoplasty.
Complications
Hearing
Tympanic membrane perforation
Tympanoplasty
Journal
Otology & neurotology open
ISSN: 2766-3604
Titre abrégé: Otol Neurotol Open
Pays: United States
ID NLM: 9918486785706676
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
18
05
2021
accepted:
05
09
2021
medline:
5
11
2021
pubmed:
5
11
2021
entrez:
29
3
2024
Statut:
epublish
Résumé
Evaluate whether elevating the tympanic membrane from the malleus during endoscopic tympanoplasty may negatively affect postoperative hearing outcomes or perforation rates by comparing 2 similar endoscopic tympanoplasty techniques. Retrospective cohort. Tertiary care center. Endoscopic over-under cartilage tympanoplasties age and gender matched to endoscopic underlay cartilage tympanoplasties between January 2015 and January 2019. Exclusion criteria included preoperative or intraoperative cholesteatoma, performance of mastoidectomy or ossicular chain reconstruction, and lack of postoperative audiogram. Endoscopic cartilage tympanoplasty via over-under or underlay technique. Pre- and postoperative pure-tone average and word recognition score, graft success. A total of 52 patients were evaluated: 26 endoscopic over-under cartilage tympanoplasties were matched to endoscopic underlay cartilage tympanoplasties. Both groups demonstrated a statistically significant improvement in air conduction hearing (9 dB [ Endoscopic over-under cartilage tympanoplasty effectively closes tympanic membrane perforations and improves hearing, without greater risk than underlay tympanoplasty. Elevating the tympanic membrane from the malleus does not confer worsen hearing outcomes.
Identifiants
pubmed: 38550354
doi: 10.1097/ONO.0000000000000005
pmc: PMC10969511
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e005Informations de copyright
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
Book royalties, Elsevier (M.A.A.).